Fetal Magnetic Resonance Imaging: Z-score Reference Ranges for a Large Patient Population in Normal Neuroimaging Measurement
Launched by GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER · May 27, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • The pregnant women in Born in Guangzhou Cohort Study
- Exclusion Criteria:
- • The fetuses with prenatal diagnosis of congenital heart disease or other congenital diseases.
- • The fetuses who are high-risk neonates at the delivery.1) preterm infants; (2) infants with extremely low birth weight (ELBW) or who are small for gestational age (SGA);
About Guangzhou Women And Children's Medical Center
Guangzhou Women and Children's Medical Center is a leading healthcare institution dedicated to advancing the health and well-being of women and children through comprehensive medical services, research, and education. As a prominent clinical trial sponsor, the center focuses on innovative studies aimed at improving maternal and pediatric health outcomes. With a commitment to evidence-based practices and collaborative partnerships, the center strives to contribute to the global body of medical knowledge while ensuring the highest standards of patient care and ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported